Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbableĀ stents, and renal stents.Ā
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
November 19, 2006
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...
November 16, 2006Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
The tiny tools of interventional cardiology known as drug-eluting stents (which happen to comprise a gargantuan U.S ...
November 16, 2006
The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the ...
November 15, 2006A Netherlands study comparing two-year outcomes of a series of 708 consecutive diabetic patients (25 percent insulin ...
November 15, 2006ACC together with AHA and other key healthcare organizations, has launched "Door to Balloon (D2B): An Alliance ...
November 12, 2006The FDA has cleared Boston Scientificās NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
November 06, 2006Results from the Danish SORT-OUT II study, the largest randomized trial to date comparing Taxus and Cypher drug-eluting ...
November 01, 2006The Certification Commission for Healthcare Information Technology is inviting organizations to submit their ambulatory ...
November 01, 2006A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...
October 30, 2006Early clinical results from Abbott's ongoing ABSORB clinical trial, the world's first study to evaluate the ...
October 25, 2006A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested ...
October 24, 2006When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by ...
October 23, 2006Boston Scientific has European CE clearance to begin marketing a private-label XIENCE V everolimus-eluting coronary ...
October 17, 2006Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now